Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Modification of high blood pressure after myocardial infarction
K. Kario
, T. G. Pickering
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Modification of high blood pressure after myocardial infarction'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
High Blood Pressure
100%
Myocardial Infarction
100%
Blood Pressure
66%
Lifestyle Modification
33%
Antihypertensive Drugs
33%
Clinical Trials
33%
High Risk
33%
Acute Myocardial Infarction
33%
Reinfarction
33%
Beta-blockers
33%
Hypertensive
33%
Angiotensin-converting Enzyme Inhibitor (ACEi)
33%
Hypertensive Population
33%
Modification Agent
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hypertension
100%
Heart Infarction
100%
Antihypertensive Agent
33%
Clinical Trial
33%
Acute Heart Infarction
33%
Dipeptidyl Carboxypeptidase Inhibitor
33%